This results in hypokinesis and outward displacement of the papillary muscle, creating increased tension on the attached chordae tendineae and preventing complete closure of the corresponding mitral valve cusp. t
Pathophysiology
Clinical features
Auscultation
S3 heart sound in advanced stages of disease
Indication of severity
vs S2-opening snap interval in Mitral stenosis, also a indication of severity
Holosystolic murmur (high-pitched, blowing)
Radiates to the left axilla and heard best over the apex (5th intercostal space at the left midclavicular line)
Intensity can be increased by increasing preload (e.g., leg raise) or afterload (e.g., handgrip) due to increased regurgitation.
Diagnostics
Initial/Screening: Transthoracic echocardiogram (TTE) to evaluate regurgitant jet, etiology, LV/LA size, and LV ejection fraction (LVEF).
Confirmatory/Pre-op: Transesophageal echocardiogram (TEE) if TTE is suboptimal, or for surgical planning/guidance.
Key Labs/Imaging:
ECG: LA enlargement, LV hypertrophy, atrial fibrillation (A-fib).
Medical Stabilization: O2, vasodilators (e.g., nitroprusside to ↓ afterload and ↑ forward flow), diuretics.
Hemodynamic Collapse: Intra-aortic balloon pump (IABP) to bridge to surgery.
Definitive: Urgent/emergent surgical repair or replacement.
Chronic Primary MR:
Symptomatic pts: Mitral valve repair (preferred) or replacement.
Asymptomatic pts: Surgery indicated if LVEF 30-60% and/or LV end-systolic dimension (LVESD) ≥ 40 mm. (Note: LVEF > 60% is normal in MR due to unloading into LA; LVEF < 60% indicates LV failure due to chronic volumn overload).c
Chronic Secondary (Functional) MR:
First-line: Guideline-directed medical therapy (GDMT) for heart failure (ACEi/ARNI, beta-blockers, MRA, SGLT2i).
Refractory: Transcatheter edge-to-edge repair (TEER, e.g., MitraClip) in highly selected pts with severe symptoms despite GDMT.